cataliesw
18 posts
Apr 04, 2024
12:11 AM
|
Clinical trials have shown that blocking CD28-CD80/CD86 signaling can sensitize chemotherapy drugs and significantly reduce tumor burden. In this case, CD80 has been served as a potential target for drug discovery against various tumors. Now, several CD80-targeting therapeutics have been discovered for tumor treatment.
|
